Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation

MLA

Song, Bakhovuddin Azamov, et al. “Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation.” Molecules; Volume 28; Issue 13; Pages: 4971, June 2023. EBSCOhost, https://doi.org/10.3390/molecules28134971.

APA

Song, B. A., Kwang-Min Lee, Jin Hur, Shakhnoza Muradillaeva, Wan-Seog Shim, Chanhee Lee, & Parkyong. (2023). Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation. Molecules; Volume 28; Issue 13; Pages: 4971. https://doi.org/10.3390/molecules28134971

Chicago

Song, Bakhovuddin Azamov, Kwang-Min Lee, Jin Hur, Shakhnoza Muradillaeva, Wan-Seog Shim, Chanhee Lee, and Parkyong. 2023. “Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation.” Molecules; Volume 28; Issue 13; Pages: 4971, June. doi:10.3390/molecules28134971.